Veryan was founded in 2005 as the result of a technology spin out from Imperial College, London, based on the pioneering work by Professor Colin Caro (Emeritus Professor of Physiological Mechanics, Dept. of Bioengineering Imperial College) on the link between vessel geometry, blood flow mechanics and vascular disease. Veryan used its understanding of swirling flow and its expertise in research and development to design, develop and patent a highly innovative three-dimensional (3D) Nitinol (nickel-titanium alloy) stent technology, BioMimics 3D.
